Cas No.: | 334827-98-4 |
Chemical Name: | 5-[2-Ethoxy-5-[(4-ethyl-1-piperazinyl)sulfonyl]-3-pyridinyl]-3-ethyl-2,6-dihydro-2-(2-methoxyethyl)-7H-pyrazolo[4,3-d]pyrimidin-7-one benzenesulfonate |
Synonyms: | Gisadenafil besylate |
SMILES: | COCCN1N=C2C(N=C(C3=C(OCC)N=CC(S(N4CCN(CC)CC4)(=O)=O)=C3)NC2=C1CC)=O.OS(C1C=CC=CC=1)(=O)=O |
Formula: | C23H33N7O5S.C6H6O3S |
M.Wt: | 677.79 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | UK-369003 (Gisadenafil besylate) is a novel, potent, selective, orally bioavailable PDE5 inhibitor with IC50 of 1.23 nM, displays 117-fold selectivity over PDE6; demonstrates efficacy in patients with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH).COPDPhase 2 Discontinued |